rs113994138
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM4_SupportingPP5_Very_Strong
The NM_139276.3(STAT3):c.1387_1389delGTG(p.Val463del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_139276.3 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- hyper-IgE recurrent infection syndrome 1, autosomal dominantInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
- STAT3-related early-onset multisystem autoimmune diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, ClinGen
- permanent neonatal diabetes mellitusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hyper-IgE recurrent infection syndrome 1, autosomal dominant Pathogenic:2Other:1
Variant summary: STAT3 c.1387_1389delGTG (p.Val463del) results in an in-frame deletion that removes Val463 from the DNA-binding domain of the encoded protein. The variant was absent in 251120 control chromosomes (gnomAD). c.1387_1389delGTG has been reported in the literature in multiple heterozygous individuals affected with Hyper IgE Syndrome, including several cases where it was confirmed to be a de novo variant (e.g. Minegishi_2007, Giacomelli_2011, Heimall_2011). These data indicate that the variant is very likely to be associated with disease. Furthermore, experimental studies have shown that the variant has a dominant-negative effect on wild-type STAT3 and diminished DNA-binding activity of STAT3 (e.g. Minegishi_2007, Okada_2018). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
not provided Pathogenic:1
The c.1387_1389delGTG variant has been published previosuly in association with hyper-IgE syndrome, including de novo occurrences (Minegishi et al., 2007; Woellner et al., 2010; Heimall et al., 2011; Giacomelli et al., 2011). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The variant results in an in-frame deletion of the Valine at residue 463, denoted p.Val463del. The deleted Valine is a conserved residue located in the DNA-binding domain of STAT3 (Minegishi et al., 2007), and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, functional studies have shown that c.1387_1389delGTG results in impaired DNA binding and regulatory activity of the STAT3 protein (Minegishi et al., 2007; Xu et al., 2015). Therefore, we consider this variant to be pathogenic. -
Hyper-IgE recurrent infection syndrome 1, autosomal dominant;C4288261:STAT3 gain of function Pathogenic:1
This variant, c.1387_1389del, results in the deletion of 1 amino acid(s) of the STAT3 protein (p.Val463del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with hyper-IgE syndrome (PMID: 17676033, 21288777, 21792878, 22751495). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 18303). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects STAT3 function (PMID: 17676033, 26384563, 27799162, 29402895). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at